Pulmonary fibrosis: pathogenesis, etiology and regulation

Wynn, 2007, Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases, J. Clin. Invest, 117,, 524, 10.1172/JCI31487

Wynn, 2004, Fibrotic disease and the T(H)1/T(H)2 paradigm, Nat. Rev. Immunol, 4,, 583, 10.1038/nri1412

Tomasek, 2002, Myofibroblasts and mechano-regulation of connective tissue remodelling, Nat. Rev. Mol. Cell Biol, 3,, 349, 10.1038/nrm809

Pardo, 2006, Matrix metalloproteases in aberrant fibrotic tissue remodeling, Proc. Am. Thorac. Soc, 3,, 383, 10.1513/pats.200601-012TK

Raghu, 2006, Incidence and prevalence of idiopathic pulmonary fibrosis, Am. J. Resp. Crit. Care Med, 174,, 810, 10.1164/rccm.200602-163OC

Daniil, 1999, A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis, Am. J. Resp. Crit. Care Med, 160,, 899, 10.1164/ajrccm.160.3.9903021

Chambers, 2003, Role of coagulation cascade proteases in lung repair and fibrosis, Eur. Respir. J. Suppl, 44,, 33s, 10.1183/09031936.03.00001003

Hamada, 2008, The role of high mobility group box1 in pulmonary fibrosis, Am. J. Respir. Cell Mol. Biol, 39,, 440, 10.1165/rcmb.2007-0330OC

Korfei, 2008, Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis, Am. J. Resp. Crit. Care Med, 178,, 838, 10.1164/rccm.200802-313OC

Dik, 2003, Thrombin contributes to bronchoalveolar lavage fluid mitogenicity in lung disease of the premature infant, Pediatr. Pulmonol, 35,, 34, 10.1002/ppul.10219

Hernandez-Rodriguez, 1995, Role of thrombin in pulmonary fibrosis, Lancet, 346,, 1071, 10.1016/S0140-6736(95)91744-6

Gabazza, 1999, Thrombin in the airways of asthmatic patients, Lung, 177,, 253, 10.1007/PL00007645

Chen, 1975, Mitogenic activity of blood components. I. Thrombin and prothrombin, Proc. Natl. Acad. Sci. USA, 72,, 131, 10.1073/pnas.72.1.131

Bogatkevich, 2001, Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway, J. Biol. Chem, 276,, 45184, 10.1074/jbc.M106441200

Chambers, 1998, Thrombin stimulates fibroblast procollagen production via proteolytic activation of protease-activated receptor 1, Biochem. J, 333, 121, 10.1042/bj3330121

Kuwano, 1999, Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis, J. Clin. Invest, 104,, 13, 10.1172/JCI5628

Vaccaro, 1985, Alveolar wall basement membranes in bleomycin-induced pulmonary fibrosis, Am. Rev. Respir. Dis, 132,, 905

McKeown, S., Richter, A.G., O'Kane, C., McAuley, D.F. & Thickett, D.R. Matrix metalloproteinase expression and abnormal lung permeability are important determinants of outcome in IPF. Eur. Respir. J.32, (2008). (E-pub ahead of print).

Hoshino, 1998, Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation, J. Allergy Clin. Immunol, 104,, 783, 10.1016/S0091-6749(98)70018-1

Murphy, 1992, The matrix metalloproteinases and their inhibitors, Am. J. Respir. Cell Mol. Biol, 7,, 120, 10.1165/ajrcmb/7.2.120

Corbel, 2002, Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis, Cell Biol. Toxicol, 18,, 51, 10.1023/A:1014471213371

Ruiz, 2003, Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis, Am. J. Physiol, 285,, L1026

Gadek, 1979, Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis, N. Engl. J. Med, 301,, 737, 10.1056/NEJM197910043011401

O'Connor, 1988, Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis, Thorax, 43,, 393, 10.1136/thx.43.5.393

Oggionni, 2006, Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis, Eur. J. Histochem, 50,, 317

O'Connor, 1994, Matrix metalloproteases and lung disease, Thorax, 49,, 602, 10.1136/thx.49.6.602

Corry, 2002, Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency, Nat Immunol, 3,, 347, 10.1038/ni773

Corry, 2004, Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines, FASEB. J, 18,, 995, 10.1096/fj.03-1412fje

Erjefalt, 1996, Eosinophils, neutrophils, and venular gaps in the airway mucosa at epithelial removal-restitution, Am. J. Resp. Crit. Care Med, 153,, 1666, 10.1164/ajrccm.153.5.8630618

Gauldie, 2002, Pro: Inflammatory mechanisms are a minor component of the pathogenesis of idiopathic pulmonary fibrosis, Am. J. Resp. Crit. Care Med, 165,, 1205, 10.1164/rccm.2202054

Piguet, 2003, Inflammation in idiopathic pulmonary fibrosis, Am. J. Resp. Crit. Care Med, 167,, 1037, 10.1164/ajrccm.167.7.952

Strieter, 2002, Con: Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis, Am. J. Resp. Crit. Care Med, 165,, 1206, 10.1164/rccm.2202055

Bringardner, 2008, The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis, Antioxid Redox Signal, 10,, 287, 10.1089/ars.2007.1897

Davies, H.R., Richeldi, L. & Walters, E.H. Immunomodulatory agents for idiopathic pulmonary fibrosis. Cochrane Database Syst. Rev. CD003134 (2003).

Richeldi, L., Davies, H.R., Ferrara, G. & Franco, F. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst. Rev. CD002880 (2003).

Selman, 2001, Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy, Ann. Intern. Med, 134,, 136, 10.7326/0003-4819-134-2-200101160-00015

Elovic, 1998, IL-4-dependent regulation of TGF-alpha and TGF-beta1 expression in human eosinophils, J. Immunol, 160,, 6121, 10.4049/jimmunol.160.12.6121

Minshall, 1997, Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma, Am. J. Respir. Cell Mol. Biol, 17,, 326, 10.1165/ajrcmb.17.3.2733

Ohno, 1996, Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation, Am. J. Respir. Cell Mol. Biol, 15,, 404, 10.1165/ajrcmb.15.3.8810646

Wenzel, 2002, TGF-beta and IL-13 synergistically increase eotaxin-1 production in human airway fibroblasts, J. Immunol, 169,, 4613, 10.4049/jimmunol.169.8.4613

Zagai, 2007, Eosinophil cationic protein stimulates TGF-beta1 release by human lung fibroblasts in vitro, Inflammation, 30,, 153, 10.1007/s10753-007-9032-4

Moodley, 2003, Macrophage recognition and phagocytosis of apoptotic fibroblasts is critically dependent on fibroblast-derived thrombospondin 1 and CD36, Am. J. Pathol, 162,, 771, 10.1016/S0002-9440(10)63874-6

Nakagome, 2006, In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung, Thorax, 61,, 886, 10.1136/thx.2005.056317

Janeway, 2002, Innate immune recognition, Annu. Rev. Immunol, 20,, 197, 10.1146/annurev.immunol.20.083001.084359

Matzinger, 2002, The danger model: a renewed sense of self, Science, 296,, 301, 10.1126/science.1071059

Holgate, 2008, Pathogenesis of asthma, Clin. Exp. Allergy, 38,, 872, 10.1111/j.1365-2222.2008.02971.x

Agostini, 2006, Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis, Proc. Am. Thorac Soc, 3,, 357, 10.1513/pats.200601-010TK

Fertin, 1991, Interleukin-4 stimulates collagen synthesis by normal and scleroderma fibroblasts in dermal equivalents, Cell Mol. Biol, 37,, 823

Sempowski, 1994, Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis, J. Immunol, 152,, 3606, 10.4049/jimmunol.152.7.3606

Strutz, 2001, TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2), Kidney Int, 59,, 579, 10.1046/j.1523-1755.2001.059002579.x

Wynn, 2003, IL-13 effector functions, Annu. Rev. Immunol, 21,, 425, 10.1146/annurev.immunol.21.120601.141142

Emura, 1990, In vitro production of B cell growth factor and B cell differentiation factor by peripheral blood mononuclear cells and bronchoalveolar lavage T lymphocytes from patients with idiopathic pulmonary fibrosis, Clin. Exp. Immunol, 82,, 133, 10.1111/j.1365-2249.1990.tb05416.x

Wallace, 1995, A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA), Clin. Exp. Immunol, 101,, 436, 10.1111/j.1365-2249.1995.tb03131.x

Buttner, 1997, Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4, Am. J. Respir. Cell Mol. Biol, 17,, 315, 10.1165/ajrcmb.17.3.2279

Booth, 2004, Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender, J. Immunol, 172,, 1295, 10.4049/jimmunol.172.2.1295

Pauleau, 2004, Enhancer-mediated control of macrophage-specific arginase I expression, J. Immunol, 172,, 7565, 10.4049/jimmunol.172.12.7565

Liu, 2004, Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6, J. Immunol, 173,, 3425, 10.4049/jimmunol.173.5.3425

Lee, 2005, Induction of Ym1/2 in mouse bone marrow-derived mast cells by IL-4 and identification of Ym1/2 in connective tissue type-like mast cells derived from bone marrow cells cultured with IL-4 and stem cell factor, Immunol. Cell Biol, 83,, 468, 10.1111/j.1440-1711.2005.01352.x

Martinez-Pomares, 2003, Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies, J. Leukoc. Biol, 73,, 604, 10.1189/jlb.0902450

Song, 2000, Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts, Cell Immunol, 204,, 19, 10.1006/cimm.2000.1687

Hesse, 2001, Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism, J. Immunol, 167,, 6533, 10.4049/jimmunol.167.11.6533

Prasse, 2006, A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18, Am. J. Resp. Crit. Care Med, 173,, 781, 10.1164/rccm.200509-1518OC

Pulichino, 2008, Identification of transforming growth factor beta1-driven genetic programs of acute lung fibrosis, Am. J. Respir. Cell Mol. Biol, 39,, 324, 10.1165/rcmb.2007-0186OC

Vidal, 2008, Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway, Genes Dev, 22,, 1747, 10.1101/gad.465908

Gangadharan, 2008, Murine gammaherpesvirus-induced fibrosis is associated with the development of alternatively activated macrophages, J. Leukoc. Biol, 84,, 50, 10.1189/jlb.0507270

Emad, 2007, Increased granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) levels in BAL fluid from patients with sulfur mustard gas-induced pulmonary fibrosis, J. Aerosol. Med, 20,, 352, 10.1089/jam.2007.0590

Baran, 2007, Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis, Am. J. Resp. Crit. Care Med, 176,, 78, 10.1164/rccm.200609-1279OC

Ishida, 2007, Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration, Am. J. Pathol, 170,, 843, 10.2353/ajpath.2007.051213

Trujillo, 2008, A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis, Am. J. Pathol, 172,, 1209, 10.2353/ajpath.2008.070832

Takatsu, 2008, IL-5 and eosinophilia, Curr. Opin. Immunol, 20,, 288, 10.1016/j.coi.2008.04.001

Reiman, 2006, Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity, Infect Immun, 74,, 1471, 10.1128/IAI.74.3.1471-1479.2006

Eklund, 1993, Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases, J. Immunol, 151,, 4266, 10.4049/jimmunol.151.8.4266

Tomimori, 2003, Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice, Eur. J. Pharmacol, 478,, 179, 10.1016/j.ejphar.2003.08.050

Garbuzenko, 2002, Human mast cells stimulate fibroblast proliferation, collagen synthesis and lattice contraction: a direct role for mast cells in skin fibrosis, Clin. Exp. Allergy, 32,, 237, 10.1046/j.1365-2222.2002.01293.x

Masuda, 2003, Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma, Clin. Exp. Allergy, 33,, 705, 10.1046/j.1365-2222.2003.01588.x

Pesce, 2006, The IL-21 receptor augments Th2 effector function and alternative macrophage activation, J. Clin. Invest, 116,, 2044, 10.1172/JCI27727

Frohlich, 2007, IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo, Blood, 109,, 2023, 10.1182/blood-2006-05-021600

Webb, 2003, Antigen-specific production of interleukin (IL)-13 and IL-5 cooperate to mediate IL-4Ralpha-independent airway hyperreactivity, Eur. J. Immunol, 33,, 3377, 10.1002/eji.200324178

Blease, 2002, Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma, Am. J. Pathol, 160,, 481, 10.1016/S0002-9440(10)64867-5

Fichtner-Feigl, 2007, Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis, J. Immunol, 178,, 5859, 10.4049/jimmunol.178.9.5859

Fichtner-Feigl, 2008, IL-13 Signaling via IL-13Ralpha(2) Induces Major Downstream Fibrogenic Factors Mediating Fibrosis in Chronic TNBS Colitis, Gastroenterology, 135,, 2003, 10.1053/j.gastro.2008.08.055

Shimamura, 2008, Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model, J. Immunol, 181,, 4656, 10.4049/jimmunol.181.7.4656

Munitz, 2008, Distinct roles for IL-13 and IL-4 via IL-13 receptor alpha1 and the type II IL-4 receptor in asthma pathogenesis, Proc. Natl. Acad. Sci. USA, 105,, 7240, 10.1073/pnas.0802465105

Kaviratne, 2004, IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent, J. Immunol, 173,, 4020, 10.4049/jimmunol.173.6.4020

Ingram, 2004, IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha, FASEB J, 18,, 1132, 10.1096/fj.03-1492fje

Zhu, 1999, Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production, J. Clin. Invest, 103,, 779, 10.1172/JCI5909

Blease, 2001, Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma, J. Immunol, 166,, 5219, 10.4049/jimmunol.166.8.5219

Yang, 2004, Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling, Cytokine, 28,, 224, 10.1016/j.cyto.2004.08.007

Belperio, 2002, Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis, Am. J. Respir. Cell Mol. Biol, 27,, 419, 10.1165/rcmb.2002-0009OC

Jakubzick, 2003, Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells, J. Immunol, 171,, 2684, 10.4049/jimmunol.171.5.2684

Kolodsick, 2004, Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts, J. Immunol, 172,, 4068, 10.4049/jimmunol.172.7.4068

Malavia, 2008, IL-13 induces a bronchial epithelial phenotype that is profibrotic, Respir. Res, 9,, 27, 10.1186/1465-9921-9-27

Murray, 2008, Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2, Int. J. Biochem. Cell Biol, 40,, 2174, 10.1016/j.biocel.2008.02.016

Kraft, 2001, IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma, J. Allergy Clin. Immunol, 107,, 602, 10.1067/mai.2001.113760

Lee, 2001, Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1), J. Exp. Med, 194,, 809, 10.1084/jem.194.6.809

Letterio, 1998, Regulation of immune responses by TGF-beta, Annu. Rev. Immunol, 16,, 137, 10.1146/annurev.immunol.16.1.137

Assoian, 1987, Expression and secretion of type beta transforming growth factor by activated human macrophages, Proc. Natl. Acad. Sci. USA, 84,, 6020, 10.1073/pnas.84.17.6020

Grotendorst, 1989, Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils, J. Cell Physiol, 140,, 396, 10.1002/jcp.1041400226

Khalil, 1996, Plasmin regulates the activation of cell-associated latent TGF-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury, Am. J. Respir. Cell Mol. Biol, 15,, 252, 10.1165/ajrcmb.15.2.8703482

Gressner, 1997, Attenuation of TGF-beta-induced apoptosis in primary cultures of hepatocytes by calpain inhibitors, Biochem. Biophys. Res. Commun, 231,, 457, 10.1006/bbrc.1996.5777

Munger, 1999, The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis, Cell, 96,, 319, 10.1016/S0092-8674(00)80545-0

Yu, 2000, Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis, Genes Dev, 14,, 163, 10.1101/gad.14.2.163

Szardening-Kirchner, C., Konrad, L., Hauck, E.W., Haag, S.M., Eickelberg, O. & Weidner, W. Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie??s disease. World J. Urol. (2008) (E-pub ahead of print).

Coker, 1997, Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis, Am. J. Pathol, 150,, 981

Chen, 2007, CD4+CD25+ T regulatory cells and TGF-beta in mucosal immune system: the good and the bad, Curr. Med. Chem, 14,, 2245, 10.2174/092986707781696591

Huber, 2006, TGF-beta and CD4+CD25+ regulatory T cells, Front Biosci, 11,, 1014, 10.2741/1859

Wahl, 2004, TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells, J. Leukoc. Biol, 76,, 15, 10.1189/jlb.1103539

Sime, 1997, Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung, J. Clin. Invest, 100,, 768, 10.1172/JCI119590

Flanders, 2004, Smad3 as a mediator of the fibrotic response, Int. J. Exp. Pathol, 85,, 47, 10.1111/j.0959-9673.2004.00377.x

Flanders, 2002, Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation, Am. J. Pathol, 160,, 1057, 10.1016/S0002-9440(10)64926-7

Lakos, 2004, Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma, Am. J. Pathol, 165,, 203, 10.1016/S0002-9440(10)63289-0

Border, 1992, Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease, Nature, 360,, 361, 10.1038/360361a0

Inazaki, 2004, Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction, Kidney Int, 66,, 597, 10.1111/j.1523-1755.2004.00779.x

Sato, 2003, Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction, J. Clin. Invest, 112,, 1486, 10.1172/JCI200319270

Stramer, 2005, Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3, J. Cell Physiol, 203,, 226, 10.1002/jcp.20215

Bonniaud, 2004, Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis, J. Immunol, 173,, 2099, 10.4049/jimmunol.173.3.2099

Zhao, 2002, Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice, Am. J. Physiol, 282,, L585

Ashcroft, 1999, Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response, Nat. Cell Biol, 1,, 260, 10.1038/12971

Ma, 2003, Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(−/−) mice, Am. J. Pathol, 163,, 1261, 10.1016/S0002-9440(10)63486-4

Proudfoot, 2002, Chemokine receptors: multifaceted therapeutic targets, Nat. Rev. Immunol, 2,, 106, 10.1038/nri722

Blease, 2001, Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia, J. Immunol, 166,, 1832, 10.4049/jimmunol.166.3.1832

Car, 1994, Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis, Am. J. Resp. Crit. Care Med, 149, 655, 10.1164/ajrccm.149.3.8118632

Emad, 2008, Relationship between eosinophilia and levels of chemokines (CCL5 and CCL11) and IL-5 in bronchoalveolar lavage fluid of patients with mustard gas-induced pulmonary fibrosis, J. Clin. Immunol, 28,, 298

Huaux, 2005, Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis, Am. J. Pathol, 167,, 1485, 10.1016/S0002-9440(10)61235-7

Puxeddu, 2006, The CC chemokine eotaxin/CCL11 has a selective profibrogenic effect on human lung fibroblasts, J. Allergy Clin. Immunol, 117,, 103, 10.1016/j.jaci.2005.08.057

Rose, 2003, Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung, Microcirculation, 10,, 273, 10.1080/mic.10.3-4.273.288

Zhang, 1994, Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis, J. Immunol, 153,, 4733, 10.4049/jimmunol.153.10.4733

Gharaee-Kermani, 2003, CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis, Cytokine, 24,, 266, 10.1016/j.cyto.2003.08.003

Wu, 2008, CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process, J. Immunol, 181,, 6384, 10.4049/jimmunol.181.9.6384

Moore, 2005, CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury, Am. J. Pathol, 166,, 675, 10.1016/S0002-9440(10)62289-4

Abe, 2001, Peripheral blood fibrocytes: differentiation pathway and migration to wound sites, J. Immunol, 166,, 7556, 10.4049/jimmunol.166.12.7556

van Deventer, 2008, C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9, Am. J. Pathol, 173,, 253, 10.2353/ajpath.2008.070732

Phillips, 2004, Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis, J. Clin. Invest, 114,, 438, 10.1172/JCI200420997

Quan, 2004, Circulating fibrocytes: collagen-secreting cells of the peripheral blood, Int. J. Biochem. Cell Biol, 36,, 598, 10.1016/j.biocel.2003.10.005

Bucala, 1994, Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair, Mol. Med, 1,, 71, 10.1007/BF03403533

Schmidt, 2003, Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma, J. Immunol, 171,, 380, 10.4049/jimmunol.171.1.380

Strieter, 2007, The role of CXC chemokines in pulmonary fibrosis, J. Clin. Invest, 117,, 549, 10.1172/JCI30562

Semenza, 2007, Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling, J. Cell Biochem, 102,, 840, 10.1002/jcb.21523

Keane, 1997, The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis, J. Immunol, 159,, 1437, 10.4049/jimmunol.159.3.1437

Antoniou, 2006, Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis, Chest, 130,, 982, 10.1378/chest.130.4.982

Burdick, 2005, CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling, Am. J. Resp. Crit. Care Med, 171,, 261, 10.1164/rccm.200409-1164OC

Keane, 1999, IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis, J. Immunol, 163,, 5686, 10.4049/jimmunol.163.10.5686

Keane, 1999, Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis, J. Immunol, 162,, 5511, 10.4049/jimmunol.162.9.5511

Peao, 1994, Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin, Anat. Rec, 238,, 57, 10.1002/ar.1092380108

Driscoll, 1992, Stimulation of rat alveolar macrophage fibronectin release in a cadmium chloride model of lung injury and fibrosis, Toxicol. Appl. Pharmacol, 116,, 30, 10.1016/0041-008X(92)90141-E

Kadler, 2008, Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators, Curr. Opin. Cell Biol, 20,, 495, 10.1016/j.ceb.2008.06.008

Lacronique, 1984, Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factor, Am. Rev. Respir. Dis, 130,, 450

Muro, 2008, An essential role for fibronectin extra type III domain A in pulmonary fibrosis, Am. J. Resp. Crit. Care Med, 177,, 638, 10.1164/rccm.200708-1291OC

Hernnas, 1992, Alveolar accumulation of fibronectin and hyaluronan precedes bleomycin-induced pulmonary fibrosis in the rat, Eur. Respir. J, 5,, 404, 10.1183/09031936.93.05040404

Lazenby, 1990, Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin, Am. Rev. Respir. Dis, 142,, 206, 10.1164/ajrccm/142.1.206

Iwano, 2002, Evidence that fibroblasts derive from epithelium during tissue fibrosis, J. Clin. Invest, 110,, 341, 10.1172/JCI0215518

Venkatesan, 2002, Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-beta(1) and interferon-gamma, Am. J. Physiol, 283,, L806

Bensadoun, 1996, Proteoglycan deposition in pulmonary fibrosis, Am. J. Resp. Crit. Care Med, 154, 1819, 10.1164/ajrccm.154.6.8970376

McGowan, 1992, Extracellular matrix and the regulation of lung development and repair, FASEB J, 6,, 2895, 10.1096/fasebj.6.11.1644255

Parra, 2007, Abnormal deposition of collagen/elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias, Thorax, 62,, 428, 10.1136/thx.2006.062687

Farahani, 2008, The hypothesis of “biophysical matrix contraction”: wound contraction revisited, Int. Wound J, 5,, 477, 10.1111/j.1742-481X.2007.00402.x

Mirastschijski, 2004, Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds, Exp. Cell Res, 299,, 465, 10.1016/j.yexcr.2004.06.007

Hinz, 2006, Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission, Eur. J. Cell Biol, 85,, 175, 10.1016/j.ejcb.2005.09.004

Singer, 1982, Fibronexus formation is an early event during fibronectin-induced restoration of more normal morphology and substrate adhesion patterns in transformed hamster fibroblasts, J. Cell Sci, 56,, 1, 10.1242/jcs.56.1.1

Thannickal, 2006, Evolving concepts of apoptosis in idiopathic pulmonary fibrosis, Proc. Am. Thorac. Soc, 3,, 350, 10.1513/pats.200601-001TK

Garcia-Alvarez, 2006, Tissue inhibitor of metalloproteinase-3 is up-regulated by transforming growth factor-beta1 in vitro and expressed in fibroblastic foci in vivo in idiopathic pulmonary fibrosis, Exp. Lung Res, 32,, 201, 10.1080/01902140600817481

Gill, 2008, Metalloproteinases and their inhibitors: regulators of wound healing, Int. J. Biochem. Cell Biol, 40,, 1334, 10.1016/j.biocel.2007.10.024

Selman, 2000, TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment?, Am. J. Physiol, 279,, L562

Fattman, 2008, Apoptosis in pulmonary fibrosis: too much or not enough?, Antioxid Redox Signal, 10,, 379, 10.1089/ars.2007.1907

Moodley, 2004, Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis, J. Pathol, 202,, 486, 10.1002/path.1531

Buhling, 2005, Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis, Respir. Res, 6,, 37, 10.1186/1465-9921-6-37

Maeyama, 2001, Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis, Eur. Respir. J, 17,, 180, 10.1183/09031936.01.17201800

Moodley, 2003, Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs, Am. J. Respir. Cell Mol. Biol, 29,, 490, 10.1165/rcmb.2002-0262OC

Plataki, 2005, Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis, Chest, 127,, 266, 10.1378/chest.127.1.266

Ramos, 2001, Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression, Am. J. Respir. Cell Mol. Biol, 24,, 591, 10.1165/ajrcmb.24.5.4333

Frankel, 2006, TNF-alpha sensitizes normal and fibrotic human lung fibroblasts to Fas-induced apoptosis, Am. J. Respir. Cell Mol. Biol, 34,, 293, 10.1165/rcmb.2005-0155OC

Erjefalt, 1995, In vivo restitution of airway epithelium, Cell Tissue Res, 281,, 305, 10.1007/BF00583399

Zahm, 1997, Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium, Cell Motil Cytoskeleton, 37,, 33, 10.1002/(SICI)1097-0169(1997)37:1<33::AID-CM4>3.0.CO;2-I

Kheradmand, 1994, Transforming growth factor-alpha enhances alveolar epithelial cell repair in a new in vitro model, Am. J. Physiol, 267, L728

Chilosi, 2002, Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63, Lab Invest, 82,, 1335, 10.1097/01.LAB.0000032380.82232.67

Erjefalt, 1997, Airway epithelial repair: breathtakingly quick and multipotentially pathogenic, Thorax, 52,, 1010, 10.1136/thx.52.11.1010

Farooqui, 2005, Multiple rows of cells behind an epithelial wound edge extend cryptic lamellipodia to collectively drive cell-sheet movement, J. Cell Sci, 118, 51, 10.1242/jcs.01577

Zhao, 2003, Direct visualization of a stratified epithelium reveals that wounds heal by unified sliding of cell sheets, FASEB J, 17,, 397, 10.1096/fj.02-0610com

Dunsmore, 1998, Matrilysin expression and function in airway epithelium, J. Clin. Invest, 102,, 1321, 10.1172/JCI1516

McGuire, 2003, Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium, Am. J. Pathol, 162,, 1831, 10.1016/S0002-9440(10)64318-0

Chen, 2008, Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity, Am. J. Pathol, 172,, 1256, 10.2353/ajpath.2008.070891

Goss, 2004, Update on cystic fibrosis epidemiology, Curr. Opin. Pulm Med, 10,, 510, 10.1097/01.mcp.0000138994.46519.72

Anderson, 1991, Demonstration that CFTR is a chloride channel by alteration of its anion selectivity, Science, 253,, 202, 10.1126/science.1712984

Jacquot, 2008, Hyperinflammation in airways of cystic fibrosis patients: what??s new?, Expert Rev. Mol. Diagn, 8,, 359, 10.1586/14737159.8.4.359

Koch, 2000, Diagnosis and treatment of cystic fibrosis, Respiration, 67,, 239, 10.1159/000029503

Ratjen, 2008, Recent advances in cystic fibrosis, Paediatr Respir Rev, 9,, 144, 10.1016/j.prrv.2008.01.004

Saiman, 2004, Microbiology of early CF lung disease, Paediatr Respir Rev, 5, S367, 10.1016/S1526-0542(04)90065-6

Hansen, 2005, Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study, J. Cyst. Fibros, 4,, 35, 10.1016/j.jcf.2004.09.001

Pai, 2001, Efficacy and safety of aerosolized tobramycin in cystic fibrosis, Pediatr. Pulmonol, 32,, 314, 10.1002/ppul.1125

Westerman, 2004, Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study, J. Cyst. Fibros, 3,, 23, 10.1016/j.jcf.2003.12.005

Nichols, 2008, Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling, Clin. Rev. Allergy Immunol, 34,, 146, 10.1007/s12016-007-8039-9

Soferman, 2006, Immunopathophysiologic mechanisms of cystic fibrosis lung disease, Isr. Med. Assoc. J, 8,, 44

Regamey, 2008, Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis, Am. J. Resp. Crit. Care Med, 177,, 837, 10.1164/rccm.200707-977OC

Gaggar, 2007, Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients, Am. J. Physiol, 293,, L96

Delacourt, 1995, Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis, Am. J. Resp. Crit. Care Med, 152,, 765, 10.1164/ajrccm.152.2.7633740

Sagel, 2005, Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis, Pediatr. Pulmonol, 39,, 224, 10.1002/ppul.20165

Hajj, 2007, Human airway surface epithelial regeneration is delayed and abnormal in cystic fibrosis, J. Pathol, 211,, 340, 10.1002/path.2118

Clarke, 1992, Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis, Science, 257,, 1125, 10.1126/science.257.5073.1125

Kent, 1997, Lung disease in mice with cystic fibrosis, J. Clin. Invest, 100,, 3060, 10.1172/JCI119861

Snouwaert, 1992, An animal model for cystic fibrosis made by gene targeting, Science, 257,, 1083, 10.1126/science.257.5073.1083

Bensalem, 2005, Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patients, Mol. Cell Proteomics, 4,, 1591, 10.1074/mcp.M500019-MCP200

Haston, 2002, Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice, Mamm. Genome, 13,, 605, 10.1007/s00335-002-2190-7

Salvatore, 2002, Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes, Am. J. Med. Genet, 111,, 88, 10.1002/ajmg.10461

Davidson, 2004, Lung pathology in response to repeated exposure to Staphylococcus aureus in congenic residual function cystic fibrosis mice does not increase in response to decreased CFTR levels or increased bacterial load, Pathobiology, 71,, 152, 10.1159/000076470

Stotland, 2000, Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis, Pediatr. Pulmonol, 30,, 413, 10.1002/1099-0496(200011)30:5<413::AID-PPUL8>3.0.CO;2-9

Durie, 2004, Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model, Am. J. Pathol, 164,, 1481, 10.1016/S0002-9440(10)63234-8

Burkhardt, 1989, Alveolitis and collapse in the pathogenesis of pulmonary fibrosis, Am. Rev. Respir. Dis, 140,, 513, 10.1164/ajrccm/140.2.513

Carver, 2007, American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects, J. Clin. Oncol, 25,, 3991, 10.1200/JCO.2007.10.9777

Vagane, 2008, Radiological and functional assessment of radiation-induced pulmonary damage following breast irradiation, Acta. Oncol, 47,, 248, 10.1080/02841860701630267

Ghafoori, 2008, Radiation-induced lung injury. Assessment, management, and prevention, Oncology (Williston Park), 22,, 37

Beinert, 1999, Oxidant-induced lung injury in anticancer therapy, Eur. J. Med. Res, 4,, 43

Rodningen, 2008, Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis, Radiother Oncol, 86,, 314, 10.1016/j.radonc.2007.09.013

Lemay, 2008, Radiation-induced lung response of AcB/BcA recombinant congenic mice, Radiat Res, 170,, 299, 10.1667/RR1319.1

Johnston, 2004, Inflammatory cell recruitment following thoracic irradiation, Exp. Lung Res, 30,, 369, 10.1080/01902140490438915

Westermann, 1999, Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat, Int. J. Radiat. Biol, 75,, 629, 10.1080/095530099140276

Barthelemy-Brichant, 2004, Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy, Int. J. Radiat. Oncol. Biol. Phys, 58,, 758, 10.1016/S0360-3016(03)01614-6

Hill, 2005, Radiation effects on the respiratory system, BJR Suppl, 27,, 75, 10.1259/bjr/34124307

Matej, 2007, Radiation-induced production of PAR-1 and TGF-beta 1 mRNA in lung of C57Bl6 and C3H murine strains and influence of pharmacoprophylaxis by ACE inhibitors, Pathol. Res. Pract, 203,, 107, 10.1016/j.prp.2006.10.006

Molteni, 2007, Effect of an angiotensin II receptor blocker and two angiotensin converting enzyme inhibitors on transforming growth factor-beta (TGF-beta) and alpha-actomyosin (alpha SMA), important mediators of radiation-induced pneumopathy and lung fibrosis, Curr. Pharm. Des, 13,, 1307, 10.2174/138161207780618777

Yang, 2007, Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury, Int. J. Radiat. Biol, 83,, 665, 10.1080/09553000701558977

Johnston, 2002, Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families, Radiat. Res, 157,, 256, 10.1667/0033-7587(2002)157[0256:RIPFEO]2.0.CO;2

Haase, 2007, Expression of the immunomodulator IL-10 in type I pneumocytes of the rat: alterations of IL-10 expression in radiation-induced lung damage, J. Histochem Cytochem, 55,, 1167, 10.1369/jhc.7A7173.2007

Sharplin, 1989, A quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the intermediate and late phases, Radiat Res, 119,, 15, 10.2307/3577364

Giotopoulos, 2007, The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes, Br. J. Cancer, 96,, 1001, 10.1038/sj.bjc.6603637

Abid, 2001, Radiation-induced and chemotherapy-induced pulmonary injury, Curr. Opin. Oncol, 13,, 242, 10.1097/00001622-200107000-00006

Sleijfer, 2001, Bleomycin-induced pneumonitis, Chest, 120,, 617, 10.1378/chest.120.2.617

Umezawa, 1967, Studies on bleomycin, Cancer, 20,, 891, 10.1002/1097-0142(1967)20:5<891::AID-CNCR2820200550>3.0.CO;2-V

Umezawa, 1974, Chemistry and mechanism of action of bleomycin, Fed. Proc, 33,, 2296

Van Barneveld, 1984, Predictive factors for bleomycin-induced pneumonitis, Am. Rev. Respir. Dis, 130,, 1078

Onuma, 1974, Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance, Cancer, 33,, 1230, 10.1002/1097-0142(197405)33:5<1230::AID-CNCR2820330507>3.0.CO;2-C

Doelman, 1990, Oxygen radicals in lung pathology, Free Radic. Biol. Med, 9,, 381, 10.1016/0891-5849(90)90015-B

Burger, 1981, Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA, J. Biol. Chem, 256,, 11636, 10.1016/S0021-9258(19)68452-8

Adamson, 1974, The pathogenesis of bloemycin-induced pulmonary fibrosis in mice, Am. J. Pathol, 77,, 185

Piguet, 1993, Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies, Am. Rev. Respir. Dis, 147,, 435, 10.1164/ajrccm/147.2.435

Piguet, 1989, Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis, J. Exp. Med, 170,, 655, 10.1084/jem.170.3.655

Scheule, 1992, Bleomycin stimulation of cytokine secretion by the human alveolar macrophage, Am. J. Physiol, 262, L386

Smith, 1998, TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury, J. Leukoc. Biol, 64,, 528, 10.1002/jlb.64.4.528

Santana, 1995, Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis, Am. J. Respir. Cell Mol. Biol, 13,, 34, 10.1165/ajrcmb.13.1.7541221

Zhang, 1995, Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis, Am. J. Pathol, 147,, 352

Hagimoto, 1997, Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice, Am. J. Respir. Cell Mol. Biol, 16,, 91, 10.1165/ajrcmb.16.1.8998084

Giri, 1993, Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice, Thorax, 48,, 959, 10.1136/thx.48.10.959

Piguet, 1993, Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica, Cytokine, 5,, 57, 10.1016/1043-4666(93)90024-Y

Hao, 2000, Bleomycin-induced pulmonary fibrosis is independent of eosinophils, J. Leukoc. Biol, 68,, 515, 10.1189/jlb.68.4.515

Izbicki, 2003, IL-4 is not a key profibrotic cytokine in bleomycin-induced lung fibrosis model, J. Immunol, 171,, 2767, 10.4049/jimmunol.171.6.2767-b

McKay, 1975, Balanitis xerotica obliterans in children, J. Urol, 114,, 773, 10.1016/S0022-5347(17)67141-6

Segel, 2003, Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis, Am. J. Physiol, 285,, L1255

Chen, 2001, Attenuation of lung inflammation and fibrosis in interferon-gamma-deficient mice after intratracheal bleomycin, Am. J. Respir. Cell Mol. Biol, 24,, 545, 10.1165/ajrcmb.24.5.4064

Sakamoto, 2002, IL-12p40(−/−) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis, Exp. Mol. Pathol, 72,, 1, 10.1006/exmp.2001.2409

Moseley, 1986, Augmentation of fibroblast proliferation by bleomycin, J. Clin. Invest, 78,, 1150, 10.1172/JCI112695

Phan, 1991, Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin, J. Clin. Invest, 87,, 148, 10.1172/JCI114964

Eder, 2006, The asthma epidemic, N. Engl. J. Med, 355,, 2226, 10.1056/NEJMra054308

Martinez, 2005, Gene-environment interactions in asthma and allergies: a new paradigm to understand disease causation, Immunol. Allergy Clin. North Am, 25,, 709, 10.1016/j.iac.2005.09.001

Cohn, 2004, Asthma: mechanisms of disease persistence and progression, Annu. Rev. Immunol, 22,, 789, 10.1146/annurev.immunol.22.012703.104716

Boulet, 2007, Airway remodelling: the future, Eur. Respir. J, 30,, 831, 10.1183/09031936.00110107

Broide, 2008, Immunologic and inflammatory mechanisms that drive asthma progression to remodeling, J. Allergy Clin. Immunol, 121,, 560, 10.1016/j.jaci.2008.01.031

Huang, 1999, Enhanced proteoglycan deposition in the airway wall of atopic asthmatics, Am. J. Resp. Crit. Care Med, 160,, 725, 10.1164/ajrccm.160.2.9809040

Ward, 2002, Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma, Thorax, 57,, 309, 10.1136/thorax.57.4.309

Angkasekwinai, 2007, Interleukin 25 promotes the initiation of proallergic type 2 responses, J. Exp. Med, 204,, 1509, 10.1084/jem.20061675

Owyang, 2006, Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract, J. Exp. Med, 203,, 843, 10.1084/jem.20051496

Sharkhuu, 2006, Mechanism of interleukin-25 (IL-17E)-induced pulmonary inflammation and airways hyper-reactivity, Clin. Exp. Allergy, 36,, 1575, 10.1111/j.1365-2222.2006.02595.x

Min, 2004, Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite, J. Exp. Med, 200,, 507, 10.1084/jem.20040590

Voehringer, 2004, Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production, Immunity, 20,, 267, 10.1016/S1074-7613(04)00026-3

Webb, 2007, Comparative roles of IL-4, IL-13, and IL-4Ralpha in dendritic cell maturation and CD4+ Th2 cell function, J. Immunol, 178,, 219, 10.4049/jimmunol.178.1.219

Hauber, 2004, IL-9 in allergic inflammation, Int. Arch. Allergy Immunol, 134,, 79, 10.1159/000078384

Woodman, 2008, Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta1, J. Immunol, 181,, 5001, 10.4049/jimmunol.181.7.5001

Coutts, 2001, Release of biologically active TGF-beta from airway smooth muscle cells induces autocrine synthesis of collagen, Am. J. Physiol, 280,, L999

Balzar, 2005, Increased TGF-beta2 in severe asthma with eosinophilia, J. Allergy Clin. Immunol, 115,, 110, 10.1016/j.jaci.2004.09.034

Batra, 2004, Clin. Exp. Allergy, 34,, 437, 10.1111/j.1365-2222.2004.01885.x

Levi-Schaffer, 1999, Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta), Proc. Natl. Acad. Sci. USA, 96,, 9660, 10.1073/pnas.96.17.9660

Sagara, 2002, Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma, J. Allergy Clin. Immunol, 110,, 249, 10.1067/mai.2002.126078

Flood-Page, 2003, Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics, J. Clin. Invest, 112,, 1029, 10.1172/JCI17974

Kang, 2007, Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12, J. Biol. Chem, 282,, 7723, 10.1074/jbc.M610764200

Phipps, 2004, Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin, J. Invest Dermatol, 122,, 1406, 10.1111/j.0022-202X.2004.22619.x

Menzies-Gow, 2003, Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics, J. Allergy Clin. Immunol, 111,, 714, 10.1067/mai.2003.1382

Flood-Page, 2003, Eosinophil??s role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway, Am. J. Resp. Crit. Care Med, 167,, 199, 10.1164/rccm.200208-789OC

O'Byrne, 2007, The demise of anti IL-5 for asthma, or not, Am. J. Resp. Crit. Care Med, 176,, 1059, 10.1164/rccm.200708-1264ED

Cho, 2004, Inhibition of airway remodeling in IL-5-deficient mice, J. Clin. Invest, 113,, 551, 10.1172/JCI19133

Humbles, 2004, A critical role for eosinophils in allergic airways remodeling, Science, 305,, 1776, 10.1126/science.1100283

Lee, 2004, Defining a link with asthma in mice congenitally deficient in eosinophils, Science, 305,, 1773, 10.1126/science.1099472

McMillan, 2005, Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway, J. Immunol, 174,, 5774, 10.4049/jimmunol.174.9.5774

Le, 2007, Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice, J. Immunol, 178,, 7310, 10.4049/jimmunol.178.11.7310

Kondo, 2006, Elimination of IL-13 reverses established goblet cell metaplasia into ciliated epithelia in airway epithelial cell culture, Allergol. Int, 55,, 329, 10.2332/allergolint.55.329

Fanta, 1985, Clinical aspects of mucus and mucous plugging in asthma, J. Asthma, 22,, 295, 10.3109/02770908509087113

Ramalingam, 2008, Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain, Nat. Immunol, 9,, 25, 10.1038/ni1544

Allahverdian, 2008, Secretion of IL-13 by airway epithelial cells enhances epithelial repair via HB-EGF, Am. J. Respir. Cell Mol. Biol, 38,, 153, 10.1165/rcmb.2007-0173OC

Booth, 2001, Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha, Am. J. Respir. Cell Mol. Biol, 25,, 739, 10.1165/ajrcmb.25.6.4659

Saito, 2003, Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro, Int. Arch. Allergy Immunol, 132,, 168, 10.1159/000073718

Richter, 2001, The contribution of interleukin (IL)-4 and IL-13 to the epithelial-mesenchymal trophic unit in asthma, Am. J. Respir. Cell Mol. Biol, 25,, 385, 10.1165/ajrcmb.25.3.4437

Chiba, Y., Nakazawa, S., Todoroki, M., Shinozaki, K., Sakai, H. & Misawa, M. Interleukin-13 Augments Bronchial Smooth Muscle Contractility with an Upregulation of RhoA Protein. Am. J. Respir. Cell Mol. Biol. (2008). (E-pub ahead of print)

Wen, 2002, Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma, Am. J. Respir. Cell Mol. Biol, 26,, 484, 10.1165/ajrcmb.26.4.4784

Zhou, 2005, Interleukin-13 augments transforming growth factor-beta1-induced tissue inhibitor of metalloproteinase-1 expression in primary human airway fibroblasts, Am. J. Physiol. Cell Physiol, 288,, C435, 10.1152/ajpcell.00035.2004

Zhou, 2007, Mechanisms of tissue inhibitor of metalloproteinase 1 augmentation by IL-13 on TGF-beta 1-stimulated primary human fibroblasts, J. Allergy Clin. Immunol, 119,, 1388, 10.1016/j.jaci.2007.02.011

Paris, 2004, Factors associated with early-stage pulmonary fibrosis as determined by high-resolution computed tomography among persons occupationally exposed to asbestos, Scand J. Work Environ. Health, 30,, 206, 10.5271/sjweh.781

Schenker, 2000, Exposures and health effects from inorganic agricultural dusts, Environ. Health Perspect, 108, 661, 10.1289/ehp.00108s4661

Von Essen, 1990, Organic dust toxic syndrome: an acute febrile reaction to organic dust exposure distinct from hypersensitivity pneumonitis, J. Toxicol. Clin. Toxicol, 28,, 389, 10.3109/15563659009038584

Buerke, 2002, Interstitial pulmonary fibrosis after severe exposure to welding fumes, Am. J. Ind. Med, 41,, 259, 10.1002/ajim.10055

Che, 1989, Pathogenesis of extrinsic allergic alveolitis and pulmonary fibrosis induced by streptomyces thermohygroscopicus, Chin. Med. J. (Engl.), 102,, 563

Cormier, 2000, High-resolution computed tomographic characteristics in acute farmer??s lung and in its follow-up, Eur. Respir. J, 16,, 56, 10.1034/j.1399-3003.2000.16a10.x

Lalancette, 1993, Farmer??s lung. Long-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors, Am. Rev. Respir. Dis, 148,, 216, 10.1164/ajrccm/148.1.216

Toubas, 1995, Extrinsic allergic alveolitis of occupational origin], Presse Med, 24,, 1391

Hillerdal, 1984, Sarcoidosis: epidemiology and prognosis. A 15-year European study, Am. Rev. Respir. Dis, 130,, 29

Nunes, 2007, Sarcoidosis, Orphanet J. Rare Dis, 2,, 46, 10.1186/1750-1172-2-46

Gaede, 2004, Differential gene expression pattern in alveolar macrophages of patients with sarcoidosis and tuberculosis, J. Mol. Med, 82,, 206, 10.1007/s00109-003-0511-2

Abehsera, 2000, Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function, AJR Am. J. Roentgenol, 174,, 1751, 10.2214/ajr.174.6.1741751

Roman, 1995, Distribution of extracellular matrices, matrix receptors, and transforming growth factor-beta 1 in human and experimental lung granulomatous inflammation, Am. J. Med. Sci, 309,, 124, 10.1097/00000441-199503000-00002

Hutyrova, 2002, Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis, Am. J. Resp. Crit. Care Med, 165,, 148, 10.1164/ajrccm.165.2.2106004

Muller-Quernheim, 1998, Sarcoidosis: immunopathogenetic concepts and their clinical application, Eur. Respir. J, 12,, 716, 10.1183/09031936.98.12030716

Rottoli, 2005, Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis, Proteomics, 5,, 1423, 10.1002/pmic.200301007

Ziegenhagen, 1998, Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis, J. Investig Med, 46,, 223

Iida, 1997, Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis, Thorax, 52,, 431, 10.1136/thx.52.5.431

Limper, 1994, Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis, Am. J. Resp. Crit. Care Med, 149,, 197, 10.1164/ajrccm.149.1.8111583

Marshall, 1996, Increased inflammatory cytokines and new collagen formation in cutaneous tuberculosis and sarcoidosis, Thorax, 51,, 1253, 10.1136/thx.51.12.1253

Salez, 1998, Transforming growth factor-beta1 in sarcoidosis, Eur. Respir. J, 12,, 913, 10.1183/09031936.98.12040913

Kline, 1993, Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis, Chest, 104,, 47, 10.1378/chest.104.1.47

Baumgartner, 1997, Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis, Am. J. Resp. Crit. Care Med, 155,, 242, 10.1164/ajrccm.155.1.9001319

Baumgartner, 2000, Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers, Am. J. Epidemiol, 152,, 307, 10.1093/aje/152.4.307

Iwai, 1994, Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure, Am. J. Resp. Crit. Care Med, 150,, 670, 10.1164/ajrccm.150.3.8087336

Jakab, 1990, Sequential virus infections, bacterial superinfections, and fibrogenesis, Am. Rev. Respir. Dis, 142,, 374, 10.1164/ajrccm/142.2.374

Meliconi, 1996, Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis, Thorax, 51,, 315, 10.1136/thx.51.3.315

Pinsker, 1981, Usual interstitial pneumonia following Texas A2 influenza infection, Chest, 80,, 123, 10.1378/chest.80.2.123

Qunn, 2002, Hyperplastic epithelial foci in honeycomb lesions in idiopathic pulmonary fibrosis, Virchows Arch, 441,, 271, 10.1007/s00428-002-0618-9

Bitterman, 1986, Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members, N. Engl. J. Med, 314,, 1343, 10.1056/NEJM198605223142103

Verleden, 2001, Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin, Eur. Respir. J. Suppl, 32,, 17s

Gribbin, 2006, Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK, Thorax, 61,, 980, 10.1136/thx.2006.062836

American Thoracic Society, 2000, Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS), Am. J. Resp. Crit. Care Med, 161, 646

Crystal, 2002, Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group, Am. J. Resp. Crit. Care Med, 166,, 236, 10.1164/rccm.2201069

Crystal, 1984, Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts), N. Engl. J. Med, 310,, 154, 10.1056/NEJM198401193100304

Gauldie, 2007, TGF-beta, Smad3 and the process of progressive fibrosis, Biochem. Soc. Trans, 35, 661, 10.1042/BST0350661

Flaherty, 2001, Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival, Am. J. Med, 110,, 278, 10.1016/S0002-9343(00)00711-7

Khalil, 1996, TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study, Am. J. Respir. Cell Mol. Biol, 14,, 131, 10.1165/ajrcmb.14.2.8630262

Xu, 2003, Release of biologically active TGF-beta1 by alveolar epithelial cells results in pulmonary fibrosis, Am. J. Physiol, 285,, L527

Pan, 1996, Co-expression of TNF alpha and IL-1 beta in human acute pulmonary fibrotic diseases: an immunohistochemical analysis, Pathol. Int, 46,, 91, 10.1111/j.1440-1827.1996.tb03584.x

Zhang, 1993, Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure, J. Immunol, 150,, 4188, 10.4049/jimmunol.150.9.4188

Antoniou, 2004, Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP), Sarcoidosis Vasc. Diffuse Lung Dis, 21,, 105

Antoniades, 1990, Platelet-derived growth factor in idiopathic pulmonary fibrosis, J. Clin. Invest, 86,, 1055, 10.1172/JCI114808

Standiford, 1993, Altered production and regulation of monocyte chemoattractant protein-1 from pulmonary fibroblasts isolated from patients with idiopathic pulmonary fibrosis, Chest, 103, 121S, 10.1378/chest.103.2_Supplement.121S

Furuie, 1997, Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis, Eur. Respir. J, 10,, 787, 10.1183/09031936.97.10040787

Jakubzick, 2004, Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia, J. Clin. Pathol, 57,, 477, 10.1136/jcp.2003.012799

Hunninghake, 1981, Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis, J. Clin. Invest, 68,, 259, 10.1172/JCI110242

Baptista, 2006, Structural features of epithelial remodeling in usual interstitial pneumonia histologic pattern, Lung, 184,, 239, 10.1007/s00408-005-2585-9

Agusti, 1991, Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis, Am. Rev. Respir. Dis, 143,, 219, 10.1164/ajrccm/143.2.219

Holsti, 2004, Regulation of postsurgical fibrosis by the programmed death-1 inhibitory pathway, J. Immunol, 172,, 5774, 10.4049/jimmunol.172.9.5774

Moore, 2001, Interleukin-10 and the interleukin-10 receptor, Annu. Rev. Immunol, 19,, 683, 10.1146/annurev.immunol.19.1.683

Garantziotis, 2006, Leukocyte-derived IL-10 reduces subepithelial fibrosis associated with chronically inhaled endotoxin, Am. J. Respir. Cell Mol. Biol, 35,, 662, 10.1165/rcmb.2006-0055OC

Arai, 2000, Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo, Am. J. Physiol, 278,, L914

Dosanjh, 1998, The bronchoalveolar lavage fluid of cystic fibrosis lung transplant recipients demonstrates increased interleukin-8 and elastase and decreased IL-10, J. Interferon Cytokine Res, 18,, 851, 10.1089/jir.1998.18.851

Millar, 2006, IL-10: another therapeutic target in idiopathic pulmonary fibrosis?, Thorax, 61,, 835, 10.1136/thx.2006.060772

Mu, 2005, IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease, J. Am. Soc. Nephrol, 16,, 3651, 10.1681/ASN.2005030297

Wynn, 1998, IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease, J. Immunol, 160,, 4473, 10.4049/jimmunol.160.9.4473

Hoffmann, 2000, IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis, J. Immunol, 164,, 6406, 10.4049/jimmunol.164.12.6406

Wilson, 2008, Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells, J. Immunol, 181,, 6942, 10.4049/jimmunol.181.10.6942

Kasaian, 2008, IL-13 as a therapeutic target for respiratory disease, Biochem Pharmacol, 76,, 147, 10.1016/j.bcp.2008.04.002

Zhu, 2002, IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling, J. Immunol, 168,, 2953, 10.4049/jimmunol.168.6.2953

Bottinger, 1996, The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice, Proc. Natl. Acad. Sci. USA, 93,, 5877, 10.1073/pnas.93.12.5877

Rodriguez-Pena, 2001, Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction, Nephrol. Dial. Transplant, 16, 34, 10.1093/ndt/16.suppl_1.34

Gurujeyalakshmi, 1998, Regulation of transforming growth factor-beta1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis, Am. J. Respir. Cell Mol. Biol, 18,, 334, 10.1165/ajrcmb.18.3.2867

Yang, 2008, Antagonizing TGF-beta induced liver fibrosis by a retinoic acid derivative through regulation of ROS and calcium influx, Biochem. Biophys. Res. Commun, 365,, 484, 10.1016/j.bbrc.2007.10.203

Cutroneo, 2007, Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression, J. Cell Physiol, 211,, 585, 10.1002/jcp.20972

Chiaramonte, 1999, An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response, J. Clin. Invest, 104,, 777, 10.1172/JCI7325

Fallon, 2000, Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent, J. Immunol, 164,, 2585, 10.4049/jimmunol.164.5.2585

Zheng, 2008, IL-13 receptor alpha2 selectively inhibits IL-13-induced responses in the murine lung, J. Immunol, 180,, 522, 10.4049/jimmunol.180.1.522

Wills-Karp, 1998, Interleukin-13: central mediator of allergic asthma, Science, 282,, 2258, 10.1126/science.282.5397.2258

Mentink-Kane, 2004, Opposing roles for IL-13 and IL-13 receptor alpha 2 in health and disease, Immunol. Rev, 202,, 191, 10.1111/j.0105-2896.2004.00210.x

Mentink-Kane, 2004, IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis, Proc. Natl. Acad. Sci. USA, 101,, 586, 10.1073/pnas.0305064101

Mu, 2002, The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1, J. Cell Biol, 157,, 493, 10.1083/jcb.200109100

Maeda, 2002, The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3), Calcif Tissue Int, 70,, 54, 10.1007/s002230010032

Alfranca, 2008, PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGFbeta/Alk5 signaling pathway, Blood, 112,, 1120, 10.1182/blood-2007-09-112268

Kim, 2005, Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells, Invest Ophthalmol Vis Sci, 46,, 840, 10.1167/iovs.04-0929

Agren, 1999, Matrix metalloproteinases (MMPs) are required for re-epithelialization of cutaneous wounds, Arch. Dermatol. Res, 291,, 583, 10.1007/s004030050459

Pourgholami, 2008, Inhibitors of vascular endothelial growth factor in cancer, Cardiovasc Hematol. Agents Med. Chem, 6,, 343, 10.2174/187152508785909528

Yoshiji, 2002, Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor, Tumour Biol, 23,, 348, 10.1159/000069792

Bizzarri, 2006, ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets, Pharmacol Ther, 112,, 139, 10.1016/j.pharmthera.2006.04.002

Jiang, 2004, Regulation of pulmonary fibrosis by chemokine receptor CXCR3, J. Clin. Invest, 114,, 291, 10.1172/JCI16861

Pochetuhen, 2007, Complex regulation of pulmonary inflammation and fibrosis by CCL18, Am. J. Pathol, 171,, 428, 10.2353/ajpath.2007.061167